ATE348156T1 - SEQUENCES SIMILAR TO COMPLEMENT RECEPTOR TYPE 1 (CR1). - Google Patents
SEQUENCES SIMILAR TO COMPLEMENT RECEPTOR TYPE 1 (CR1).Info
- Publication number
- ATE348156T1 ATE348156T1 AT98910864T AT98910864T ATE348156T1 AT E348156 T1 ATE348156 T1 AT E348156T1 AT 98910864 T AT98910864 T AT 98910864T AT 98910864 T AT98910864 T AT 98910864T AT E348156 T1 ATE348156 T1 AT E348156T1
- Authority
- AT
- Austria
- Prior art keywords
- lys
- scr
- lhr
- val
- asp
- Prior art date
Links
- 102000006834 complement receptors Human genes 0.000 title 2
- 108010047295 complement receptors Proteins 0.000 title 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 108020004705 Codon Proteins 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 abstract 1
- 101000668170 Homo sapiens RNA-binding motif, single-stranded-interacting protein 2 Proteins 0.000 abstract 1
- 102100039690 RNA-binding motif, single-stranded-interacting protein 2 Human genes 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 239000004074 complement inhibitor Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Escalators And Moving Walkways (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Replacement of codons in DNA encoding the first three SCRs of LHR-A of CR1 with others encoding the predicted amino acids in the CR1-like sequence can give rise to chimeric genes which can be expressed to give active complement inhibitors with functional complement inhibitory, including anti-haemolytic activity. There is provided a soluble polypeptide comprising, in sequence, one to four short consensus repeats (SCR) selected from SCR 1, 2, 3 and 4 of long homologous repeat A (LHR-A) as the only structurally and functionally intact SCR domains of CR1 and including at least SCR3, in which one or more of the native amino acids are substituted with the following: Val 4, Asp 19, Scr 53, Lys 57, Ala 74, Asp 79, Arg 84, Pro 91, Asn 109, Lys 116, Val 119, Ala 132, Thr 137, Ile 139, Ser 140, Tyr 143, His 153, Leu 156, Arg 159, Lys 161, Lys 177, Gly 230, Ser 235, His 236.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9704519.9A GB9704519D0 (en) | 1997-03-05 | 1997-03-05 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE348156T1 true ATE348156T1 (en) | 2007-01-15 |
Family
ID=10808712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98910864T ATE348156T1 (en) | 1997-03-05 | 1998-03-05 | SEQUENCES SIMILAR TO COMPLEMENT RECEPTOR TYPE 1 (CR1). |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6833437B2 (en) |
| EP (1) | EP0979276B1 (en) |
| JP (1) | JP2001516212A (en) |
| AT (1) | ATE348156T1 (en) |
| AU (1) | AU6509098A (en) |
| DE (1) | DE69836629D1 (en) |
| GB (1) | GB9704519D0 (en) |
| WO (1) | WO1998039433A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9905503D0 (en) | 1999-03-10 | 1999-05-05 | Adprotech Plc | Novel compound formulations and methods of delivery |
| EP1307554A2 (en) * | 2000-08-02 | 2003-05-07 | Amgen Inc. | C3b/c4b complement receptor-like molecules and uses thereof |
| EP1820861A3 (en) * | 2000-08-02 | 2007-08-29 | Amgen Inc. | C3B/C4B complement receptor-like molecules and uses thereof |
| GB0220936D0 (en) * | 2002-09-05 | 2002-10-23 | Adprotech Ltd | Modified therapeutic agents |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1413587A2 (en) * | 1991-05-03 | 2004-04-28 | Washington University | Modified complement system regulator |
| US5833989A (en) * | 1992-06-24 | 1998-11-10 | Adprotech Plc | Soluble CR1 derivatives |
| CA2171953C (en) | 1993-09-24 | 2003-02-04 | John P. Atkinson | Modified truncated complement system regulators |
| US5907030A (en) * | 1995-01-25 | 1999-05-25 | University Of Southern California | Method and compositions for lipidization of hydrophilic molecules |
| GB9614871D0 (en) * | 1996-07-15 | 1996-09-04 | Smithkline Beecham Plc | Compounds |
-
1997
- 1997-03-05 GB GBGB9704519.9A patent/GB9704519D0/en active Pending
-
1998
- 1998-03-05 JP JP53829998A patent/JP2001516212A/en not_active Ceased
- 1998-03-05 EP EP98910864A patent/EP0979276B1/en not_active Expired - Lifetime
- 1998-03-05 AT AT98910864T patent/ATE348156T1/en not_active IP Right Cessation
- 1998-03-05 DE DE69836629T patent/DE69836629D1/en not_active Expired - Lifetime
- 1998-03-05 WO PCT/GB1998/000727 patent/WO1998039433A1/en active IP Right Grant
- 1998-03-05 AU AU65090/98A patent/AU6509098A/en not_active Abandoned
- 1998-03-05 US US09/380,682 patent/US6833437B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20030064431A1 (en) | 2003-04-03 |
| AU6509098A (en) | 1998-09-22 |
| JP2001516212A (en) | 2001-09-25 |
| US6833437B2 (en) | 2004-12-21 |
| GB9704519D0 (en) | 1997-04-23 |
| DE69836629D1 (en) | 2007-01-25 |
| WO1998039433A1 (en) | 1998-09-11 |
| EP0979276B1 (en) | 2006-12-13 |
| EP0979276A1 (en) | 2000-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sellos et al. | Molecular cloning of hemocyanin cDNA from Penaeus vannamei (Crustacea, Decapoda): structure, evolution and physiological aspects | |
| KR900017607A (en) | Proteinase inhibitors, preparation methods thereof, and pharmaceutical products containing them | |
| KR940703860A (en) | Novel human Kunizin protease inhibitors and variants thereof (A NOVEL HUMAN KUNITZ-TYPE PROTEASE INHIBITOR AND VARIANTS THEREOF) | |
| DE69740074D1 (en) | Fibroblast growth factors homologues | |
| KR870008030A (en) | Wax for Pigment Cell Tumors | |
| RU94036773A (en) | Domain i of protease inhibitor, dna, vector, cell, method of protease inhibitor preparing, pharmaceutical composition, the use of domain i | |
| DE69939327D1 (en) | FUNCTIONAL ANTAGONISTS OF HEDGEHOG ACTIVITY | |
| CA2104678A1 (en) | Protein-induced morphogenesis | |
| HK1089788A1 (en) | A recombinant protein with cancer suppression action, its encoding gene and use | |
| AR006517A1 (en) | POLYPEPTIDE THAT REACHES A TOTAL AROUND 30 AMINO ACIDS; RESULTANT SUBSTANCE, PEPTIDOMIMETICO AND PHARMACEUTICAL COMPOSITION; USES OF THE POLYPEPTIDE AND PROCESS FOR THE SYNTHESIS OF THE POLYPEPTIDE. | |
| Popoff et al. | DNA sequence of exoenzyme C3, an ADP-ribosyltransferase encoded by Clostridium botulinum C and D phages | |
| DE69534600D1 (en) | NUCLEOTIDE AND AMINO ACID SEQUENCES OF THE GENES OF CROP PROTEIN 1 AND THE CORE PROTEIN OF HEPATITIS C VIRUS | |
| MXPA02000465A (en) | CYCLIC PEPTIDE DERIVATIVES AS INHIBITORS OF INTEGRIN alphaV. | |
| MX9203654A (en) | PURIFICATION, CLONING AND CHARACTERIZATION OF THE GENE FOR INTERLEUKIN I. | |
| DE69836629D1 (en) | THE COMPLEMENT RECEPTOR TYPE 1 (CR1) SIMILAR SEQUENCES | |
| GB9310657D0 (en) | Retrovirus | |
| IL102346A0 (en) | Cysteine depleted il-6 muteins | |
| Naoyuki et al. | Use of the deoxyinosine-containing probe to isolate and sequence cDNA encoding the fusion (F) glycoprotein of Sendai virus (HVJ) | |
| Imajoh et al. | Fragment of an endogenous inhibitor produced in Escherichia coli for calcium-activated neutral protease (CANP) retains an inhibitory activity | |
| CA2265500A1 (en) | Novel semaphorin gene: semaphorin y | |
| Kawasaki et al. | Gene organization and 5′-flanking region sequence of conglutinin: a C-type mammalian lectin containing a collagen-like domain | |
| RU97103147A (en) | DNA SEQUENCES ENCODING HUMAN PROTEINS TX AND TU RELATED TO CONVERTERING INTERLEUKIN-1-BETA ENZYME | |
| JP2002538775A5 (en) | ||
| Nakayama et al. | Nucleotide sequences of two members of the chicken H4 histone-encoding gene family | |
| Chan et al. | The primary structures of rat ribosomal proteins L4 and L41 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |